Page last updated: 2024-11-11

echinacin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

echinacin: used in primary chronic polyarthritis therapy; from Echinacea purpurea [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
EchinaceagenusA genus of perennial herbs used topically and internally. It contains echinacoside, GLYCOSIDES; INULIN; isobutyl amides, resin, and SESQUITERPENES.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Echinacea purpureaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID6439941
CHEMBL ID3597472
MeSH IDM0095756

Synonyms (17)

Synonym
acbglu
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxyoxan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate
j64j7o64hy ,
unii-j64j7o64hy
105815-90-5
4h-1-benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-((6-o-(3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-beta-d-glucopyranosyl)oxy)-, (e)-
apigenin-7-o-(6''-o-4-coumaroyl)-beta-glucopyranoside
echinacin
2-propenoic acid, 3-(4-hydroxyphenyl)-, 6'-ester with 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one, (e)-
4h-1-benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-((6-o-((2e)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl)-.beta.-d-glucopyranosyl)oxy)-
4h-1-benzopyran-4-one, 5-hydroxy-2-(4-hydroxyphenyl)-7-((6-o-((2e)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl)-.beta.-d-glucopyranosyl)oxy)-
echinacin [inci]
echinacin (glycoside)
apigenin 7-o-(6''-o-p-coumaroylglucoside)
CHEMBL3597472
Q27281248
DTXSID001021352

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1236853Inhibition of Bacillus stearothermophilus alpha-glucosidase2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID1236856Cytotoxicity against human WS1 cells2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID1236855Retention time of the compound by HPLC-SPE-NMR analysis2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199019 (61.29)18.7374
1990's8 (25.81)18.2507
2000's3 (9.68)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.31 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.04 (4.65)
Search Engine Demand Index73.18 (26.88)
Search Engine Supply Index4.00 (0.95)

This Compound (30.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (12.12%)5.53%
Reviews2 (6.06%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]